HealthDay - MONDAY, May 31 (HealthDay News)-- The newly approved therapeutic prostate cancer vaccine, Provenge, is safe and has few side effects, a new study finds.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.